D. Machover
- Oncology top 2%
- Colorectal Cancer Treatments and Studies 26
- Cancer Treatment and Pharmacology 22
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 8
-
- Lymphoma Diagnosis and Treatment 13
-
- Gastric Cancer Management and Outcomes 13
- Lung Cancer Treatments and Mutations 8
- Hematology top 5%
-
- Cancer Research and Treatments 8
-
- Chronic Lymphocytic Leukemia Research 7
D. Machover
80 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Oncology 1.5k
- Hepatology 299
- Pathology and Forensic Medicine 446
- Pulmonary and Respiratory Medicine 616
- Hematology 191
Countries citing papers authored by D. Machover
This map shows the geographic impact of D. Machover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Machover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Machover more than expected).
Fields of papers citing papers by D. Machover
This network shows the impact of papers produced by D. Machover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Machover. The network helps show where D. Machover may publish in the future.
Co-authorship network
The 25 scholars most cited alongside D. Machover, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2019 | 23 | |
| 3 | 2018 | 6 | |
| 4 | A Review of the Evolution of Systemic Chemotherapy in the Management of Colorectal Cancerbreakdown → | 2014 | 414 |
| 5 | 2010 | 1 | |
| 6 | 2009 | 45 | |
| 7 | 2009 | 23 | |
| 8 | 2009 | 5 | |
| 9 | 2007 | 71 | |
| 10 | 2007 | 9 | |
| 11 | 2001 | 13 | |
| 12 | 2001 | 37 | |
| 13 | 1999 | 24 | |
| 14 | 1993 | 7 | |
| 15 | 1993 | 3 | |
| 16 | 1991 | 31 | |
| 17 | 1991 | 5 | |
| 18 | 1988 | 43 | |
| 19 | Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine. | 1978 | 47 |
| 20 | [Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)]. | 1978 | 2 |
About D. Machover
D. Machover is a scholar working on Oncology, Pathology and Forensic Medicine and Hepatology, having authored 85 papers that have together received 2.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (26 papers), Cancer Treatment and Pharmacology (22 papers), Gastric Cancer Management and Outcomes (13 papers), Lymphoma Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (8 papers), Cancer Research and Treatments (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). The work is most often cited by research in Oncology (1.5k citations), Hepatology (299 citations) and Pathology and Forensic Medicine (446 citations). D. Machover has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Emma Goldschmidt, L Schwarzenberg, G. Metzger, F A Gibson, Nicholas J. Petrelli, Hans‐Joachim Schmoll, Bengt Gustavsson, Göran Carlsson, Arnaud Roth and J. L. Misset. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Cancer, Scientific Reports and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.